Dr. Carlos L. Arteaga

Dr. Carlos L. Arteaga, MD, is a world-renowned medical oncologist and physician-scientist specializing in breast cancer biology and precision oncology. He serves as Director of the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center and holds the Lisa K. Simmons Distinguished Chair in Comprehensive Oncology. Dr. Arteaga earned his medical degree from the Universidad de Guayaquil in Ecuador, completed his residency in Internal Medicine at Emory University, and pursued fellowship training in Medical Oncology at The University of Texas Health Science Center at San Antonio. He is board-certified in Internal Medicine and Medical Oncology and is recognized as a global leader in translational breast cancer research.

Dr. Arteaga’s research has elucidated mechanisms of resistance to HER2-targeted therapies, hormonal therapies, and PI3K inhibitors, leading to the development of novel combination strategies for breast cancer treatment. His work has been instrumental in defining biomarkers for therapeutic response and advancing clinical trials that integrate molecular profiling into treatment decisions. Dr. Arteaga has authored over 300 peer-reviewed publications and has served as principal investigator for multiple landmark clinical studies in breast cancer.

Beyond his research, Dr. Arteaga is a committed educator and national thought leader, having served as President of the American Association for Cancer Research (AACR). He is deeply involved in mentoring the next generation of translational researchers and plays a pivotal role in shaping national strategies for cancer precision medicine. Through his leadership, mentorship, and dedication to innovative cancer research, Dr. Carlos L. Arteaga continues to drive advancements in breast cancer care and translational oncology.